Achmea Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-103,660
Closed -$18.4M 331
2020
Q1
$18.4M Buy
+103,660
New +$19.5M 0.84% 27
2019
Q4
Sell
-34,431
Closed -$5.79M 559
2019
Q3
$5.79M Sell
34,431
-6,542
-16% -$1.07M 0.23% 114
2019
Q2
$6.86M Buy
+40,973
New +$5.67M 0.26% 96
2018
Q4
Sell
-21,605
Closed -$4.12M 506
2018
Q3
$4.12M Buy
21,605
+12,032
+126% +$2.21M 0.16% 162
2018
Q2
$1.6M Hold
9,573
0.06% 308
2018
Q1
$1.61M Hold
9,573
0.05% 326
2017
Q4
$1.56M Buy
9,573
+4,020
+72% +$721K 0.05% 328
2017
Q3
$1.14M Hold
5,553
0.06% 311
2017
Q2
$1.35M Sell
5,553
-18,823
-77% -$4.42M 0.08% 295
2017
Q1
$5.82M Buy
+24,376
New +$5.68M 0.27% 97

Other funds holding AGN

Achmea Investment Management's AGN Position: Q2 2020 in Review

Achmea Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 103,660 shares — an estimated $18.4M sold.

Achmea Investment Management first reported a position in AGN in Q1 2017 and held it in 10 quarters. The position peaked at $18.4M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Achmea Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Achmea Investment Management sold 103,660 Allergan plc shares in Q2 2020, an estimated $18.4M.
  • Achmea Investment Management first reported a position in Allergan plc in Q1 2017 and held it in 10 quarters.
  • Achmea Investment Management's Allergan plc position peaked at $18.4M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Achmea Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.